Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions (Q40865994)

24 September 2017

1 reference

title

Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions (English)

1 reference

24 September 2017

Lazarus HM

1

1 reference

24 September 2017

1 January 1998

1 reference

24 September 2017

1 reference

24 September 2017

16

1 reference

24 September 2017

2

1 reference

24 September 2017

102-126

1 reference

24 September 2017

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Complete Remissions in Metastatic Breast Cancer Treated with Combination Drug Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Chemotherapy of advanced breast cancer: outcome and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Alkylating agent resistance: in vitro studies with human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Autologous bone marrow transplantation. Current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Dose-response effect of adjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Changing Trends in Allogeneic Bone Marrow Transplantation for Leukemia in the 1980s

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Prospective evaluation of pulmonary function in cancer patients treated with total body irradiation, high-dose melphalan, and autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Mechanism of action of taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Sequences of taxol and cisplatin: a phase I and pharmacologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Quantum leaps in treatment of high-risk breast cancer? Prove it!

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Application of peripheral blood progenitors to dose-intensive therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Micrometastases and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Does in vitro bone marrow purging improve the outcome after autologous bone marrow transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Human hematopoietic precursors in long-term culture: single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony-forming cells when cultured with marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Isolation of a candidate human hematopoietic stem-cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Transplantation of CD34+ hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

O6-methylguanine-DNA methyltransferase in normal and malignant tissue of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Immune reconstitution after bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Humanization of an anti-p185HER2 antibody for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Biology of tumor micrometastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Quality of life in adult cancer patients treated with bone marrow transplantation--a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Patients' adjustment to cancer: the Mental Adjustment to Cancer (MAC) scale vs clinical ratings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Quality of life following bone marrow transplantation for breast cancer: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Variation in approval by insurance companies of coverage for autologous bone marrow transplantation for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Advanced breast cancer: use of resources and cost implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909809039764

Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo

21 January 2018

1 reference

11 February 2024

https://opencitations.net/index/api/v1/citations/10.1056/NEJM199508033330503

Identifiers

DOI

10.3109/07357909809039764

1 reference

24 September 2017

1 reference

PubMed ID

9512676